Insurance coverage losses, changes in insurance plans and cuts to provider networks could happen if the Affordable Care Act is repealed, repealed and replaced or is weakened because of lack of support from the Trump administration. Continue reading
The takeaway was that they would like to see less regulatory burden for providers and help foster information sharing among trusted health care entities. Continue reading
State-run electronic databases that collect opioid prescription information are being hailed as an effective tool to curb opioid abuse in a new report released last week by the Centers for Disease Control and Prevention (CDC).
The CDC report got a lot of press, mainly for its primary findings that opioid prescriptions have dropped in recent years but still remained three times higher in 2015 than in 1999. The peak opioid prescribing year was 2010, according to the CDC. Continue reading
Now that Senate Republicans have delayed action on their Obamacare “repeal and replace” bill until after the Independence Day recess, let’s take a moment to talk about innovation.
Last week’s blog post by Food and Drug Administration Commissioner Scott Gottlieb, M.D., is providing digital health innovators with a new roadmap to navigate pre- and post-market federal oversight of their products.
The topline for journalists is that in the coming months, the FDA will publish new guidance on digital health products and launch programs to monitor the industry, according to the blog post. Key timeframes and details, culled from Gottlieb’s post: Continue reading